Divergent Mast Cell Responses Modulate Antiviral Immunity During Influenza Virus Infection

Abstract

Influenza A virus (IAV) is a respiratory pathogen that infects millions of people each year. Both seasonal and pandemic strains of IAV are capable of causing severe respiratory disease with a high risk of respiratory failure and opportunistic secondary infection. A strong inflammatory cytokine response is a hallmark of severe IAV infection. The widespread tissue damage and edema in the lung during severe influenza is largely attributed to an overexuberant production of inflammatory cytokines and cell killing by resident and infiltrating leukocytes. Mast cells (MCs) are a sentinel hematopoietic cell type situated at mucosal sites, including the lung. Poised to react immediately upon detecting infection, MCs produce a vast array of immune modulating molecules, including inflammatory cytokines, chemokines, and proteases. As such, MCs have been implicated as a source of the immunopathology observed in severe influenza. However, a growing body of evidence indicates that MCs play an essential role not only in inducing an inflammatory response but in suppressing inflammation as well. MC-derived immune suppressive cytokines are essential to the resolution of a number of viral infections and other immune insults. Absence of MCs prolongs infection, exacerbates tissue damage, and contributes to dissemination of the pathogen to other tissues. Production of cytokines such as IL-10 and IL-6 by MCs is essential for mitigating the inflammation and tissue damage caused by innate and adaptive immune cells alike. The two opposing functions of MCs—one pro-inflammatory and one anti-inflammatory—distinguish MCs as master regulators of immunity at the site of infection. Amongst the first cells to respond to infection or injury, MCs persist for the duration of the infection, modulating the recruitment, activation, and eventual suppression of other immune cells. In this review, we will discuss the immune modulatory roles of MCs over the course of viral infection and propose that the immune suppressive mediators produced by MCs are vital to minimizing immunopathology during influenza infection.

Synthetic vaccine affords full protection to mice against lethal challenge of influenza B virus of both genetic lineages

“…immunopathology(Murphy-Schafer and Paust, 2021). Moreover, the drastically reduced IL-17 level in the rAd-HA2DN30F group is noteworthy, as IL-17 plays an important role in mucosal immunity against pathogens (Flo ´rido et al…”

Temporal Modulation of Drug Desensitization Procedures

“…Importantly, FcγRIIB also binds to different IgG isotypes that are responsible for decreasing the symptoms of IgE-based allergies, and are necessary to prevent and sustain immunological tolerance [10]. As a consequence of FcγRIIB-IgG activity, impaired antigen/IgE/FcεRI complex internalization may subsequently be in place [11]. Challenging with the same antigen at a later time without eliciting an immune response is a hallmark of DS, however different antigens, including those that induce calcium fluxes needed for signaling will still elicit an allergenic response [12].…”

The Immune Response to Respiratory Viruses: From Start to Memory

“…Mast cells are located in mucosal sites and have been implicated in influenza disease pathogenesis, both as amplifiers of inflammation, as well as regulators of the immune response, through production of cytokines including IL-6 and IL-10. 54 Endothelial cells are intricately linked to both inflammation and coagulation and damage to these cells in the lungs can lead to pulmonary edema. Some respiratory viruses, including some strains of influenza, can directly infect endothelial cells.…”